Patents by Inventor Sven Kuehnert

Sven Kuehnert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7420056
    Abstract: Substituted bicyclic imidazo-3-yl-amine compounds are provided, as well as processes for the production thereof and pharmaceutical formulations containing these compounds. The use of these compounds for the production of pharmaceutical formulations and related methods of treatment are also provided.
    Type: Grant
    Filed: March 14, 2007
    Date of Patent: September 2, 2008
    Assignee: Gruenenthal GmbH
    Inventors: Sven Kuehnert, Stefan Oberboersch, Corinna Sundermann, Michael Haurand, Ruth Jostock, Klaus Schiene, Thomas Tzschentke, Thomas Christoph, Dagmar Kaulartz, Saskia Zemolka
  • Publication number: 20080167315
    Abstract: Substituted tetrahydropyrrolopyrazine compounds corresponding to the formula I: processes for their preparation, pharmaceutical compositions comprising these compounds and the use of these compounds for the treatment and/or inhibition of pain and other disorders or disease states at least partly mediated by KCNQ2/3 K+ channels.
    Type: Application
    Filed: October 17, 2007
    Publication date: July 10, 2008
    Applicant: GRUENENTHAL GmbH
    Inventors: Beatrix Merla, Thomas Christoph, Stefan Oberboersch, Klaus Schiene, Gregor Bahrenberg, Robert Frank, Sven Kuehnert, Wolfgang Schroeder
  • Patent number: 7300939
    Abstract: Substituted 1-propiolylpiperazine compounds corresponding to formula I in which X denotes N or C—R2, and n is an integer from 0 to 8, a method for producing such substituted 1-propiolylpiperazine compounds, pharmaceutical compositions containing such substituted 1-propiolylpiperazine compounds, and the use of such substituted 1-propiolylpiperazine compounds for modulating mGluR5 receptor activity or for treating or inhibiting pain and various other conditions, especially conditions at least partly mediated by the mGluR5 receptor.
    Type: Grant
    Filed: January 4, 2007
    Date of Patent: November 27, 2007
    Assignee: Gruenenthal GmbH
    Inventors: Sven Kuehnert, Stefan Oberboersch, Michael Haurand, Ruth Jostock, Klaus Schiene
  • Publication number: 20070208083
    Abstract: para-Alkyl-substituted N-(4-hydroxy-3-methoxybenzyl)-cinnamic acid amide compounds, processes for the preparation thereof, pharmaceutical compositions containing these compounds, and the use of these compounds for treating or inhibiting specific diseases or disorders.
    Type: Application
    Filed: February 12, 2007
    Publication date: September 6, 2007
    Applicant: Gruenenthal GmbH
    Inventors: Sven Kuehnert, Robert Frank, Ruth Jostock